Chesapeake Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Chesapeake Capital's LLY Position: Q3 2026 in Review
Chesapeake Capital increased its Eli Lilly (LLY) stake by 601% in Q3 2026, buying an estimated $2.05M and bringing the position to 2,026 shares worth $2.34M. The position accounts for 1.86% of the portfolio, ranked #25.
Chesapeake Capital first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Chesapeake Capital held 2,026 shares of Eli Lilly worth $2.34M as of Q3 2026.
- Chesapeake Capital bought 1,737 Eli Lilly shares in Q3 2026, an estimated $2.05M.
- Eli Lilly made up 1.86% of Chesapeake Capital's portfolio in Q3 2026, its #25 holding.
- Chesapeake Capital first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Chesapeake Capital's 13F filing for Q3 2026, filed 9 Nov 2026.